Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools ACC

ACC

Programs, trials, and reported response and survival for adenoid cystic carcinoma.

Data as of 11.07.2026

All studies

Puxitatug Samrotecan (P-Sam, AZD8205)

NCT07162480

AstraZeneca · Phase 2 · Recruiting · Enrollment 28

NCT07162480

Catalyst Primary completion. 12.31.2029. ClinicalTrials.gov primary completion date. This is a registry date, not a company readout.

ArmPopulationDoseEstimandComparatorEfficacy

No efficacy figure is in this file for this study.